Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer
Current Medical Research and Opinion2015cited by 43position: middledoi
Effect of a genomic classifier test on clinical practice decisions for patients with high‐risk prostate cancer after surgery
British Journal of Urology2014cited by 59position: lastdoi